Actual medication label and appearance may vary
Peptide Treatment
Semax + Selank
Choose a treatment option
Semax and Selank are synthetic neuro-peptides originally developed by the Institute of Molecular Genetics of the Russian Academy of Sciences. While they share a similar origin, they serve distinct purposes: Semax is primarily used for cognitive enhancement and neuroprotection, while Selank is utilized for its anxiolytic (anti-anxiety) and mood-stabilizing properties.
Check eligibilityNeither is FDA-approved to diagnose, treat, cure, or prevent any disease or illness.
Why it works
Key benefits
- Cognitive Support (Semax): Improved focus, memory retention, and mental clarity.
- Emotional Balance (Selank): Reduction in symptoms of anxiety and improved emotional resilience.
- Neuroprotection: Support for brain health during periods of high stress or following neurological injury.
- ADHD/Executive Function: Some users report improved task-switching and reduced mental fatigue.
Mechanism
How it works
Semax: A fragment of ACTH (Adrenocorticotropic hormone) that lacks hormonal activity. It increases the expression of BDNF (Brain-Derived Neurotrophic Factor), which acts like "fertilizer" for neurons, promoting neuroplasticity and protecting brain cells from oxidative stress and hypoxia. Selank: A synthetic analog of the naturally occurring peptide Tuftsin. It modulates the expression of Interleukin-6 (IL-6) and influences the balance of neurotransmitters like serotonin and norepinephrine. It is unique because it provides anxiolytic effects without the sedation or "mental clouding" typical of benzodiazepines.
Frequently asked questions
FAQs
The acute effects on focus (Semax) or calm (Selank) may be felt within 30–60 minutes of administration. However, the neuro-restorative benefits involving BDNF and neuroplasticity typically require 3–6 weeks of consistent use.
Semax: Irritability, mild insomnia, or temporary hair thinning (rarely reported with long-term high doses). Selank: Mild sedation (rare), or a temporary change in sense of smell (if using nasal spray). General: Injection site redness or itching.
Research & Studies
Evidence at a Glance
- 1.
Gusev, E. I., et al. (2005). Semax in the treatment of acute ischemic stroke. Neuroscience and Behavioral Physiology.
- 2.
Shadrina, M., et al. (2010). Selank and its anxiolytic effects: Influence on the expression of Interleukin-6. Journal of Molecular Biology.
- 3.
Agapov, I. I., et al. (2012). The effect of Semax on the level of BDNF in the brain. Molecular Genetics, Microbiology and Virology.
Interested in Semax + Selank?
Take a short assessment and a licensed provider will review if this treatment is right for you.
Clinical Guidance Disclaimer
The information provided in this document is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. It should never replace sound clinical judgment or personalized advice of a qualified healthcare professional. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or treatment protocol. Never disregard professional medical advice or delay in seeking it because of something you have read in these materials.
Liability & Indemnification
By utilizing this information, the user acknowledges and agrees that REBL and its affiliates, providers, and staff are not liable for any direct, indirect, or consequential damages resulting from the use or misuse of the information provided herein. Any reliance on the materials contained in this document is solely at the user's own risk.
Proprietary Rights & Use Restrictions
This document and its contents are the proprietary property of REBL. Unauthorized use, duplication, reproduction, or distribution of these materials—in whole or in part—without express written consent is strictly prohibited.